Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - doxazosin mesilate - oral tablet - 2mg

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - doxazosin mesilate 2.43mg equivalent to doxazosin 2 mg;   - tablet - 2 mg - active: doxazosin mesilate 2.43mg equivalent to doxazosin 2 mg   excipient: lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - doxazosin mesilate - oral tablet - 2mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - doxazosin mesilate - oral tablet - 2mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - doxazosin mesilate - oral tablet - 2mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - doxazosin mesilate - oral tablet - 2mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - doxazosin mesilate - oral tablet - 2mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - doxazosin mesilate - oral tablet - 2mg

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

clinect nz pty limited - doxazosin mesilate 2.44mg equivalent to 2 mg doxazosin;   - tablet - 2 mg - active: doxazosin mesilate 2.44mg equivalent to 2 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

clinect nz pty limited - doxazosin mesilate 4.87mg equivalent to 4 mg doxazosin;   - tablet - 4 mg - active: doxazosin mesilate 4.87mg equivalent to 4 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.